facebook linkedin twitter

Shalala, Gaetz Seek to Reschedule Cannabis and Develop National Research Agenda

September 20, 2019 by Sean Trambley

Reps. Donna Shalala, D-Fla., and Rep. Matt Gaetz, R-Fla., introduced the Expanding Cannabis Research and Information Act, bipartisan legislation that would facilitate research into the potential medical benefits and public health impacts of marijuana. 

The bill would develop a national cannabis research agenda, direct the U.S. Department of Health and Human Services to collect data on the health impacts of cannabis, establish a National Institutes of Health “Centers of Excellence” research designation, and reclassify cannabis as a Schedule III controlled substance.

Currently, 11 states and the District of Columbia have legalized adult cannabis use, while 33 states have legalized medical cannabis use. However, the Drug Enforcement Administration continues to classify cannabis as a Schedule I controlled substance with no medical benefit. 

The Expand Cannabis Research and Information Act would allow for a dramatic expansion in research around the health benefits and public safety impacts of cannabis use.

“For years now, states across the country have been liberalizing their cannabis laws without making corresponding investments in developing a better scientific understanding of the short and long-term benefits and effects of cannabis on human health,” Rep. Shalala said. “By rescheduling cannabis and directing our national research infrastructure to study and collect data on how it impacts health outcomes, we are not only bringing federal cannabis policy into the 21st century, but we’re also guaranteeing that we do so safely.”

“I am proud to work with Congresswoman Shalala on the Expanding Cannabis Research and Information Act,” Gaetz said. “This bipartisan and bicameral legislation will improve, expedite, and streamline cannabis research: by rescheduling cannabis to Schedule III, this bill will lessen the conflict between states and the federal government, and by designating “Centers of Excellence in Cannabis Research,” it will help unlock cures for America’s most vulnerable populations.”

Health

FDA Panel Takes Up Tough Questions on J&J COVID-19 Boosters

WASHINGTON (AP) — U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson's single-shot COVID-19 vaccine... Read More

WASHINGTON (AP) — U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when — and whether using a competing brand for the second dose might provide better protection. The push for boosters kicked off last month after... Read More

FDA Panel Endorses Lower-Dose Moderna COVID Shot for Booster

U.S. health advisers said Thursday that some Americans who received Moderna's COVID-19 vaccine should get a half-dose booster to bolster... Read More

U.S. health advisers said Thursday that some Americans who received Moderna's COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other... Read More

Nursing Schools See Applications Rise, Despite COVID Burnout

STORRS, Conn. (AP) — Nurses around the U.S. are getting burned out by the COVID-19 crisis and quitting, yet applications... Read More

STORRS, Conn. (AP) — Nurses around the U.S. are getting burned out by the COVID-19 crisis and quitting, yet applications to nursing schools are rising, driven by what educators say are young people who see the global emergency as an opportunity and a challenge. Among them... Read More

FDA Spells Out Lower Sodium Goals for Food Industry

NEW YORK (AP) — Food companies are coming under renewed pressure to use less salt after U.S. regulators spelled out... Read More

NEW YORK (AP) — Food companies are coming under renewed pressure to use less salt after U.S. regulators spelled out long-awaited guidelines aimed at reducing sodium levels in dozens of foods including condiments, cereals, french fries and potato chips. The voluntary goals finalized Wednesday for 163... Read More

October 13, 2021
by Alexa Hornbeck
Gene Editing Treatment Used in Human Subjects With Rare Genetic Blindness

WASHINGTON — New data presented by researchers from Editas Medicine, a leading genome editing company, reveals that gene editing treatments... Read More

WASHINGTON — New data presented by researchers from Editas Medicine, a leading genome editing company, reveals that gene editing treatments are not only safe in humans, but may hold promise of treating a rare retinal disease that leads to blindness. “We believe these findings validate the... Read More

October 13, 2021
by Alexa Hornbeck
How Telehealth is Helping Address Veteran Food Insecurity

WASHINGTON -- The COVID-19 pandemic has impacted veterans' access to food, leading to greater food insecurity, and according to officials... Read More

WASHINGTON -- The COVID-19 pandemic has impacted veterans' access to food, leading to greater food insecurity, and according to officials from the United States Department of Veterans Affairs, telehealth is now helping to combat the issue.  “The COVID-19 pandemic certainly has been impactful for many Americans,... Read More

News From The Well
scroll top